<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02948179</url>
  </required_header>
  <id_info>
    <org_study_id>CZKIPLA-ADPKD-003</org_study_id>
    <nct_id>NCT02948179</nct_id>
  </id_info>
  <brief_title>Using Preimplantation Genetic Diagnosis in Autosomal Dominant Polycystic Kidney Disease Patients: a Multicenter Clinical Trial</brief_title>
  <acronym>ESPERANCE</acronym>
  <official_title>Efficacy and Safety of Preimplantation Genetic Diagnosis in Blocking Pathogenic Gene Inheritance for Autosomal Dominant Polycystic Kidney Disease: a Multicenter Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Changlin Mei</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>The First Affiliated Hospital of Anhui Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The First Affiliated Hospital with Nanjing Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Shandong Provincial Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Tang-Du Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Shengjing Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Second Xiangya Hospital of Central South University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Reproductive &amp; Genetic Hospital of CITIC-Xiangya</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Shanghai Changzheng Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Autosomal dominant polycystic kidney disease (ADPKD) is the most common monogenic hereditary
      kidney disease in humans. ADPKD may affect all the generations of the ADPKD family and the
      probability of ADPKD is 50% in the second generation for each gender. It has been confirmed
      that PKD1 and PKD2 are two pathogenic genes of ADPKD. Nowadays, the investigators have
      established an effective gene detection technology platform for PKD1/2 gene with long
      fragment PCR and next generation sequencing. First, the investigators performed genetic
      testing in patients with clinically diagnosed ADPKD and strong fertility desire, but afraid
      of hereditary risk. Using Preimplantation genetic diagnosis, including multiple annealing and
      looping-based amplification cycles amplification technique, the investigators successfully
      screened out healthy embryos by In Vitro Fertilization. Then the investigators transplanted
      embryos returned to the parent. When the baby is born, using umbilical cord blood gene
      detection, the investigators confirmed that the neonates do not inherit genetic defects form
      parents. The investigators have succeeded in one couple. The investigators design a
      multicenter clinical trial to confirm those procedures efficacy and safety.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2016</start_date>
  <completion_date type="Anticipated">December 2019</completion_date>
  <primary_completion_date type="Anticipated">September 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Healthy baby Rate without pathogenic gene inheritance</measure>
    <time_frame>through study completion, an average of 2 year</time_frame>
    <description>The investigators will do umbilical cord blood gene detection for the baby to confirm with or without pathogenic gene inheritance. The investigators will compare two groups of healthy newborns rate.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Success rate in pretest of preimplantation genetic diagnosis</measure>
    <time_frame>through study completion, an average of 2 year</time_frame>
    <description>Using couples blood to do pretest of preimplantation genetic diagnosis in Peripheral blood mononuclear lymphocyte.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Technical failure rate of preimplantation genetic diagnosis.</measure>
    <time_frame>Amniotic fluid puncture test (pregnancy 16 to 19 weeks ) and Birth day</time_frame>
    <description>The rate of amniotic fluid puncture test or umbilical cord blood gene detection confirm the offspring containing pathogenic gene mutation.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Oocyte retrieval rate</measure>
    <time_frame>through study completion, an average of 2 years</time_frame>
    <description>The proportion of good eggs obtained after ovulation induction</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Good quality embryo rate</measure>
    <time_frame>through study completion, an average of 2 years</time_frame>
    <description>The well-developed blastocyst ratio obtained after intracytoplasmic sperm injection</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pregnancy rate</measure>
    <time_frame>Four weeks after embryo transplantation</time_frame>
    <description>Successful pregnancy rate of transplanted embryo</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Take home baby rate</measure>
    <time_frame>Two week after neonatus birth day</time_frame>
    <description>Healthy newborn birth rate in preimplantation genetic diagnosis group</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The total kidney volume change rate</measure>
    <time_frame>From enroll to postpartum 6 months</time_frame>
    <description>The investigators do twice kidney MRI scan for calculating total kidney volume change rate between enroll and postpartum 6 months.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The estimated glomerular filtration rate change</measure>
    <time_frame>From enroll to postpartum 6 months</time_frame>
    <description>The investigators do twice serum creatinine test between enroll and postpartum 6 months, then using CKD-EPI formula to calculate eGFR.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>The incidence of ovarian hyperstimulation syndrome</measure>
    <time_frame>through study completion, an average of 2 years</time_frame>
    <description>the incidence of ovarian hyperstimulation syndrome</description>
  </other_outcome>
  <other_outcome>
    <measure>The incidence of organ injuries</measure>
    <time_frame>through study completion, an average of 2 years</time_frame>
    <description>the incidence of organ injuries</description>
  </other_outcome>
  <other_outcome>
    <measure>The incidence of infection</measure>
    <time_frame>through study completion, an average of 2 years</time_frame>
    <description>the incidence of infection</description>
  </other_outcome>
  <other_outcome>
    <measure>The incidence of abortion rate</measure>
    <time_frame>through study completion, an average of 2 years</time_frame>
    <description>the incidence of abortion rate</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Polycystic Kidney, Type 1 Autosomal Dominant Disease</condition>
  <arm_group>
    <arm_group_label>Preimplantation genetic diagnosis group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>ADPKD patients will complete the whole process of preimplantation genetic diagnosis with healthy baby without pathogenic gene inheritance.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Natural pregnancy group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>ADPKD patients, pathogenic mutations in PKD1, have natural pregnancy without preimplantation genetic diagnosis. The investigators will do umbilical cord blood gene detection for the baby.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Preimplantation Genetic Diagnosis</intervention_name>
    <description>Using Preimplantation genetic diagnosis, including multiple annealing and looping-based amplification cycles amplification technique, the investigators have had screened out healthy embryos by In Vitro Fertilization. Then the investigators transplanted embryos returned to the parent. Finally, participants will have healthy baby without pathogenic gene inheritance.</description>
    <arm_group_label>Preimplantation genetic diagnosis group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Only one ADPKD patient in one couple without gender limitation

          -  Wife has age limitation from 20 years to 35 years

          -  ADPKD ADPKD diagnosis with or without family history

          -  Find out specific pathogenic mutations in the PKD1 gene with at least one of the
             following: one of family patients done kidney transplantation or renal replacement
             therapy before 58 years old; one of family patients died of complications before 55
             years old; the patient with total kidney volume more than 650ml; the patient with
             total kidney volume increase rate more than 6% every year; the patient's PKD1 mutation
             belongs to truncated gene mutation.

          -  Both husband and wife have assisted reproductive conditions and will

          -  Pregnancy compliance with Chinese laws

          -  Signed informed consent

        Exclusion Criteria:

          -  Active pathogenic microorganism infection, such as hepatitis B or C, HIV, pulmonary
             tuberculosis, giant cell virus, fungi or other contraindications for preimplantation
             genetic diagnosis and so on

          -  Any one of the couple has used any drugs which may lead to abnormal reproductive
             system function, reproductive cell abnormalities, pregnancy risk increases in the past
             3 months, or has history of drug abuse

          -  Any one of the couple has malignancy

          -  The wife has uncontrolled hypertension or refractory hypertension

          -  The wife has diabetes mellitus

          -  The wife has albuminuria

          -  The wife has autoimmune disease

          -  The wife has other disorders or functional abnormalities, such as liver or renal
             dysfunction, which may be aggravated by pregnancy or assisted reproduction

          -  Allergy to drugs or related products which cannot avoid in our study

          -  Participating in other clinical studies in last 3 months

          -  Participants cannot follow the study program

          -  Other conditions that the researchers considered unsuitable for participation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>changlin Mei, Master</last_name>
    <role>Principal Investigator</role>
    <affiliation>Institute of Nephrology, Changzheng Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>wen Li, doctor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Center of Reproductive Medicine, Changzheng Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Yiyi Ma, doctor</last_name>
    <phone>+8613661679863</phone>
    <email>dukemm@126.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Bo Yang, doctor</last_name>
    <phone>+8613585694444</phone>
    <email>sternothyroid@live.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>The First Affiliated Hospital of Anhui Medical University</name>
      <address>
        <city>Hefei</city>
        <state>Anhui</state>
        <zip>230000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>dawei Chen</last_name>
      <phone>+8615056057296</phone>
    </contact>
    <investigator>
      <last_name>yunxia Cao, doctor</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>yonggui Wu, doctor</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Reproductive &amp; Genetic Hospital of CITIC-Xiangya</name>
      <address>
        <city>Changsha</city>
        <state>Hunan</state>
        <zip>410000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>juan Du</last_name>
      <phone>+8618684675296</phone>
    </contact>
    <investigator>
      <last_name>ge Lin, Doctor</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Second Xiangya Hospital of Central South University</name>
      <address>
        <city>Changsha</city>
        <state>Hunan</state>
        <zip>410000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>xun zhou</last_name>
      <phone>+8613755026744</phone>
    </contact>
    <investigator>
      <last_name>hong Liu, doctor</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The First Affiliated Hospital with Nanjing Medical University</name>
      <address>
        <city>Nanjing</city>
        <state>Jiangsu</state>
        <zip>210000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>jiandong Shen, doctor</last_name>
      <email>jiandongsh@163.com</email>
    </contact>
    <investigator>
      <last_name>changying Xing, doctor</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>jiandong Shen, doctor</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Shengjing Hospital</name>
      <address>
        <city>Shenyang</city>
        <state>Liaoning</state>
        <zip>110000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>jiao Jiao</last_name>
      <phone>+8618940252509</phone>
      <email>13889284796@163.com</email>
    </contact>
    <investigator>
      <last_name>detian Li</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>xiuxia Wang, doctor</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Shandong Provincial Hospital</name>
      <address>
        <city>Ji'nan</city>
        <state>Shandong</state>
        <zip>250000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>fajuan Chen</last_name>
      <phone>+8613187057355</phone>
      <email>chengfajuan2009@163.com</email>
    </contact>
    <investigator>
      <last_name>rong Wang, doctor</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>junhao Yan, doctor</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Shanghai Changzheng Hospital</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>yiyi Ma, doctor</last_name>
      <phone>+8613661679863</phone>
      <email>dukemm@126.com</email>
    </contact>
    <contact_backup>
      <last_name>dongping Chen, doctor</last_name>
      <phone>+8613764362569</phone>
      <email>13764362569@163.com</email>
    </contact_backup>
    <investigator>
      <last_name>shengqiang Yu, doctor</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>ningxia Sun, doctor</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Tang-Du Hospital</name>
      <address>
        <city>Xi'an</city>
        <state>Shanxi</state>
        <zip>710000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>zhanting Li</last_name>
      <phone>+8613572503218</phone>
    </contact>
    <contact_backup>
      <last_name>jie Zhang</last_name>
      <phone>+8618681853253</phone>
    </contact_backup>
    <investigator>
      <last_name>jifeng Sun, Master</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>xiaohong Wang, Doctor</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>April 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 20, 2016</study_first_submitted>
  <study_first_submitted_qc>October 26, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 28, 2016</study_first_posted>
  <last_update_submitted>April 24, 2017</last_update_submitted>
  <last_update_submitted_qc>April 24, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 26, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Shanghai Changzheng Hospital</investigator_affiliation>
    <investigator_full_name>Changlin Mei</investigator_full_name>
    <investigator_title>Professor, Director of kidney Institute</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Kidney Diseases</mesh_term>
    <mesh_term>Polycystic Kidney Diseases</mesh_term>
    <mesh_term>Polycystic Kidney, Autosomal Dominant</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

